Visualization of cortical neoangiogenesis after combined revascularization surgery in moyamoya disease using silent MRA

Neuroradiology. 2024 Oct 23. doi: 10.1007/s00234-024-03486-w. Online ahead of print.

Abstract

Purpose: To investigate postsurgical indirect cortical neoangiogenesis in patients with moyamoya disease (MMD) using silent magnetic resonance angiography (MRA).

Methods: We studied 44 patients with MMD (63 hemispheres) who were previously revascularized with combined bypass surgery (23 and 40 hemispheres in pediatric and adult patients, respectively). They underwent follow-up for postoperative bypass patency using time-of-flight (TOF)-MRA and silent MRA between January 2022 and December 2023. The mean duration from surgery to MRA was 8.5 years (range, 1.2-22.3 years). Two observers independently rated the revascularization as follows: 0 (near-complete signal loss or no signal); 1, poor (slightly visible donor arteries); 2, good (acceptable revascularization around the brain surface); and 3, excellent (good quality of revascularization with perfusion from the cortical surface into the middle cerebral artery).

Results: Silent MRA visualized indirect bypass significantly better than TOF-MRA (2.6 ± 0.7 and 1.4 ± 0.8) (P < 0.01). In silent MRA, the mean score of indirect bypass was significantly higher than that of direct bypass (2.6 ± 0.7 and 1.7 ± 1.0; P < 0.01) and indicated good indirect bypass development in both children and adults (91.3% and 85.0%; score ≥ 2). Children exhibited a higher rate of excellent indirect bypass patency than adults (73.9% and 55.0%; score 3). Poor bypass development in indirect bypass (8 hemispheres, mean age: 35.5 ± 17.5 years, mean follow-up period: 11.3 years) was significantly observed in male patients (P < 0.01).

Conclusion: Silent MRA enables better precision in postsurgical visualization of indirect cortical neoangiogenesis during long-term follow-up and reveals indirect bypass development even in adult patients.

Keywords: Cortical neoangiogenesis; Indirect bypass; Moyamoya disease; Silent MRA; UTE-MRA.